Literature DB >> 3960438

Behavior of mild cervical dysplasia during long-term follow-up.

K Nasiell, V Roger, M Nasiell.   

Abstract

Five hundred and fifty-five women with cervical cytologically diagnosed mild cervical dysplasia were followed by cytology without major treatment. Biopsies were performed in 14% resulting in no significant influence on the outcome of the studied material. Regression to normal occurred in 62% (follow-up 39 months), progression to severe dysplasia/carcinoma in situ/invasive carcinoma in 16% (invasive carcinoma: two patients), and persistence of dysplasia in 22%. Life table analysis calculated the risk of progression of mild dysplasia to be 250 to 800/100,000 women/year. A comparison with the incidence of carcinoma in situ, four of 100,000 women/year, illustrates the yearly risk for a woman with mild dysplasia as 560 times greater than for a woman without cervical dysplasia to develop severe dysplasia/carcinoma in situ/invasive carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3960438     DOI: 10.1097/00006250-198605000-00012

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  36 in total

1.  Cervical cancer in the developing world.

Authors:  J Sherris; C Herdman; C Elias
Journal:  West J Med       Date:  2001-10

Review 2.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

3.  Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.

Authors:  Wen-Fang Cheng; Chien-Nan Lee; Yi-Ning Su; Ming-Cheng Chang; Wen-Chun Hsiao; Chi-An Chen; Chang-Yao Hsieh
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 4.  Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.

Authors:  J M Walsh
Journal:  West J Med       Date:  1998-11

5.  Cancer of the cervix - from bleak past to bright future; a review, with an emphasis on cancer of the cervix in malaysia.

Authors:  Othman Nor Hayati
Journal:  Malays J Med Sci       Date:  2003-01

6.  Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Jorge Morales; Greg Rydzak; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

7.  Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.

Authors:  Hsin-Hung Wu; Yu-Fan Liu; Shun-Fa Yang; Wea-Lung Lin; Shiuan-Chih Chen; Chih-Ping Han; Hsiang-Ling Wang; Long-Yau Lin; Po-Hui Wang
Journal:  Tumour Biol       Date:  2016-10-04

8.  Importance of negative result of cervical biopsy directed by colposcopy.

Authors:  P Byrne; J Jordan; D Williams; C Woodman
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

9.  Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.

Authors:  A D Santin; P L Hermonat; A Ravaggi; M Chiriva-Internati; D Zhan; S Pecorelli; G P Parham; M J Cannon
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

10.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.